接受贝拉西普治疗的肾移植受者接种SARS-CoV-2 mRNA疫苗后的免疫反应 - Suppr

Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.

作者信息

Noble Johan, Langello Antoine, Bouchut William, Lupo Julien, Lombardo Dorothee, Rostaing Lionel

机构信息

Nephrology, Hemodialysis, Apheresis, and Kidney Transplantation Department, University Hospital of Grenoble-Alpes, Grenoble, France.

University Grenoble-Alpes, Grenoble, France.

出版信息

Transplantation. 2021 Nov 1;105(11):e259-e260. doi: 10.1097/TP.0000000000003923.

DOI:10.1097/TP.0000000000003923

PMID:34387243

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8549124/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac0/8549448/3d927bd37923/tp-105-e259-g001.jpg

相似文献

Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.接受贝拉西普治疗的肾移植受者接种SARS-CoV-2 mRNA疫苗后的免疫反应

Transplantation. 2021 Nov 1;105(11):e259-e260. doi: 10.1097/TP.0000000000003923.

Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept-treated Renal Transplant Patients.贝拉西普治疗的肾移植患者接种mRNA疫苗后的抗SARS-CoV-2 T细胞反应

Transplantation. 2021 Sep 1;105(9):e99. doi: 10.1097/TP.0000000000003812.

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.接受贝拉西普治疗的肾移植受者对第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的体液和细胞免疫反应

Transplantation. 2022 May 1;106(5):e264-e265. doi: 10.1097/TP.0000000000004100. Epub 2022 Mar 14.

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.在接受贝那普利特的肾移植受者中，SARS-CoV-2 mRNA 疫苗接种后的免疫原性和反应原性。

Transplantation. 2021 Sep 1;105(9):2119-2123. doi: 10.1097/TP.0000000000003824.

Clinical outcomes of SARS-CoV-2 infection in kidney transplant recipients on belatacept: a single-center experience.接受贝拉西普治疗的肾移植受者感染新型冠状病毒2的临床结果：单中心经验

Transpl Infect Dis. 2024 Apr;26(2):e14253. doi: 10.1111/tid.14253. Epub 2024 Feb 13.

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept.接受贝拉西普治疗的肾移植受者在两次注射mRNA疫苗后，抗严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）的体液和T细胞反应不佳。

Transplantation. 2021 Sep 1;105(9):e94-e95. doi: 10.1097/TP.0000000000003784.

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.肾移植受者接受贝利尤单抗治疗后，对 3 剂 mRNA 疫苗的抗体反应较弱。

Am J Transplant. 2021 Dec;21(12):4043-4051. doi: 10.1111/ajt.16814. Epub 2021 Sep 12.

COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.基于mRNA的SARS-CoV-2疫苗接种后肾移植受者发生的新型冠状病毒肺炎

Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。

Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.

Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.肾移植受者接种 SARS-CoV-2 疫苗后的体液免疫反应：免疫抑制治疗的作用。

Transplant Proc. 2022 Nov;54(9):2454-2456. doi: 10.1016/j.transproceed.2022.09.019. Epub 2022 Oct 3.

引用本文的文献

Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the Future.贝拉西普在肾移植中的应用：回顾过去，塑造未来。

Transpl Int. 2025 May 20;38:14412. doi: 10.3389/ti.2025.14412. eCollection 2025.

Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future.共刺激阻断与实体器官移植：过去、现在与未来

Kidney Int Rep. 2023 Sep 3;8(12):2529-2545. doi: 10.1016/j.ekir.2023.08.037. eCollection 2023 Dec.

Response of antibody titers to SARS-CoV-2 vaccination and clinical outcomes during the predominance of the Omicron variant in Colombia.在哥伦比亚奥密克戎变种占主导期间，抗体滴度对新冠病毒疫苗接种的反应及临床结果

SAGE Open Med. 2023 Jul 21;11:20503121231187754. doi: 10.1177/20503121231187754. eCollection 2023.

Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients.预测肾移植受者对COVID-19疫苗持续体液免疫反应的因素。

Adv Ther. 2023 Sep;40(9):3956-3970. doi: 10.1007/s12325-023-02580-4. Epub 2023 Jul 1.

Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.肾移植受者额外接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗剂量的有效性、免疫原性和危害：一项系统评价

Vaccines (Basel). 2023 Apr 18;11(4):863. doi: 10.3390/vaccines11040863.

Low Performance of Sinovac Vaccine Particularly With Belatacept Therapy in a Study With Different Types of COVID-19 Vaccines in Transplanted Patients.在一项针对移植患者的不同类型 COVID-19 疫苗的研究中，与贝拉西普治疗相比，科兴疫苗表现不佳。

Transplant Proc. 2023 Apr;55(3):500-507. doi: 10.1016/j.transproceed.2023.02.034. Epub 2023 Mar 1.

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的免疫原性：系统评价和荟萃分析。

Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis.免疫功能低下人群接种 SARS-CoV-2 疫苗后第 1、2、3 针的血清转化率：系统评价和荟萃分析。

Virol J. 2022 Aug 8;19(1):132. doi: 10.1186/s12985-022-01858-3.

Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的体液和细胞免疫反应：系统评价和荟萃分析。

Transpl Infect Dis. 2022 Dec;24(6):e13926. doi: 10.1111/tid.13926. Epub 2022 Aug 12.

Risk Factors for Weak Antibody Response of SARS-CoV-2 Vaccine in Adult Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis.成人实体器官移植受者对 SARS-CoV-2 疫苗弱抗体反应的危险因素：系统评价和荟萃分析。

Front Immunol. 2022 Jun 14;13:888385. doi: 10.3389/fimmu.2022.888385. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献